ORBIMED ADVISORS LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$8.0B
Holdings
141
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (141 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PRLDPRELUDE THERAPEUTICS INC | 15,594,877 | $469.9B | 5905.77% | |
| 2 | SWTXSPRINGWORKS THERAPEUTICS INC | 7,406,307 | $353.1B | 4437.54% | |
| 3 | ALXNALEXION PHARMACEUTICALS INC | 2,309,500 | $264.3B | 3321.64% | Call |
| 4 | PMVPPMV PHARMACEUTICALS INC | 7,330,423 | $260.2B | 3270.79% | |
| 5 | —TURNING POINT THERAPEUTICS I | 2,745,327 | $239.8B | 3014.41% | |
| 6 | HZNPHORIZON THERAPEUTICS PUB L | 3,008,755 | $233.7B | 2937.59% | |
| 7 | IOVAIOVANCE BIOTHERAPEUTICS INC | 6,645,100 | $218.8B | 2749.52% | |
| 8 | MRTXEURMIRATI THERAPEUTICS INC | 1,317,000 | $218.7B | 2748.65% | |
| 9 | MRKMERCK & CO. INC | 2,589,100 | $214.8B | 2699.36% | |
| 10 | BMYBRISTOL-MYERS SQUIBB CO | 3,549,100 | $214.0B | 2689.42% | |
| 11 | BIIBBIOGEN INC | 715,900 | $203.1B | 2552.57% | |
| 12 | BSXBOSTON SCIENTIFIC CORP | 4,847,300 | $185.2B | 2327.94% | |
| 13 | VRTXVERTEX PHARMACEUTICALS INC | 666,100 | $181.3B | 2278.22% | |
| 14 | AFIBACUTUS MED INC | 5,477,958 | $163.2B | 2051.78% | |
| 15 | NTRANATERA INC | 2,110,700 | $152.5B | 1916.46% | |
| 16 | —PREVAIL THERAPEUTICS INC | 13,822,463 | $140.7B | 1768.60% | |
| 17 | ARQTARCUTIS BIOTHERAPEUTICS INC | 4,673,850 | $136.9B | 1721.23% | |
| 18 | NBIXNEUROCRINE BIOSCIENCES INC | 1,301,715 | $125.2B | 1573.28% | |
| 19 | BNRBURNING ROCK BIOTECH LTD | 4,746,075 | $119.0B | 1496.09% | |
| 20 | HUMHUMANA INC | 280,300 | $116.0B | 1458.15% | |
| 21 | ASNDASCENDIS PHARMA A/S | 734,500 | $113.3B | 1424.65% | |
| 22 | RPTXREPARE THERAPEUTICS INC | 3,426,325 | $105.4B | 1325.11% | |
| 23 | ETNBGBP89BIO INC | 3,729,442 | $95.7B | 1202.80% | |
| 24 | DC4DEXCOM INC | 226,400 | $93.3B | 1173.04% | |
| 25 | TBPHTHERAVANCE BIOPHARMA INC | 6,219,110 | $92.0B | 1155.70% | |
| 26 | PASGPASSAGE BIO INC | 6,962,899 | $91.3B | 1147.33% | |
| 27 | 1T7TRICIDA INC | 9,614,280 | $87.1B | 1094.81% | |
| 28 | ISRGINTUITIVE SURGICAL INC | 112,800 | $80.0B | 1005.96% | |
| 29 | TORCEURADICET BIO INC | 6,708,507 | $79.8B | 1002.54% | |
| 30 | CNCCENTENE CORP DEL | 1,335,700 | $77.9B | 979.25% | |
| 31 | AGIOAGIOS PHARMACEUTICALS INC | 2,207,321 | $77.3B | 971.02% | |
| 32 | SRPTSAREPTA THERAPEUTICS INC | 539,049 | $75.7B | 951.45% | |
| 33 | ORICORIC PHARMACEUTICALS INC | 2,921,967 | $73.1B | 918.51% | |
| 34 | AUPHAURINIA PHARMACEUTICALS INC | 4,754,000 | $70.0B | 880.15% | |
| 35 | XLRNACCELERON PHARMA INC | 601,066 | $67.6B | 850.13% | |
| 36 | KROSKEROS THERAPEUTICS INC | 1,679,417 | $64.8B | 814.15% | |
| 37 | EX9EXELIXIS INC | 2,404,100 | $58.8B | 738.80% | |
| 38 | —LOGICBIO THERAPEUTICS INC | 6,466,783 | $58.7B | 738.02% | |
| 39 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 1,125,700 | $57.7B | 725.83% | |
| 40 | —GRAYBUG VISION INC | 4,475,847 | $56.9B | 715.02% | |
| 41 | EWEDWARDS LIFESCIENCES CORP | 706,500 | $56.4B | 708.79% | |
| 42 | —IMARA INC | 2,719,902 | $55.3B | 695.35% | |
| 43 | —NOVUS THERAPEUTICS INC | 3,183,314 | $54.4B | 684.18% | |
| 44 | NSTGEURNANOSTRING TECHNOLOGIES INC | 1,183,100 | $52.9B | 664.70% | |
| 45 | CRSPCRISPR THERAPEUTICS AG | 630,004 | $52.7B | 662.30% | |
| 46 | EHTHEHEALTH INC | 638,558 | $50.4B | 634.05% | |
| 47 | TELATELA BIO INC | 3,027,542 | $50.1B | 629.40% | |
| 48 | PGNYPROGYNY INC | 1,675,500 | $49.3B | 619.77% | |
| 49 | MGTXMEIRAGTX HLDGS PLC | 3,713,820 | $49.2B | 618.02% | |
| 50 | ATRCATRICURE INC | 1,228,189 | $49.0B | 615.94% | |
| 51 | SYKSTRYKER CORPORATION | 235,000 | $49.0B | 615.46% | |
| 52 | TMOTHERMO FISHER SCIENTIFIC INC | 110,300 | $48.7B | 612.10% | |
| 53 | ATNXEURATHENEX INC | 3,977,950 | $48.1B | 604.98% | |
| 54 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 4,584,344 | $47.2B | 593.49% | |
| 55 | CHNGUSDCHANGE HEALTHCARE INC | 3,093,700 | $44.9B | 564.22% | |
| 56 | CRNXCRINETICS PHARMACEUTICALS IN | 2,753,567 | $43.1B | 542.32% | |
| 57 | KALAKALA PHARMACEUTICALS INC | 5,465,030 | $41.0B | 515.17% | |
| 58 | ABBVABBVIE INC | 464,000 | $40.6B | 510.82% | |
| 59 | —FUSION PHARMACEUTICALS INC | 3,224,770 | $38.8B | 487.19% | |
| 60 | SCPHSCPHARMACEUTICALS INC | 4,797,148 | $35.7B | 449.20% | |
| 61 | QUREUNIQURE NV | 969,079 | $35.7B | 448.59% | |
| 62 | VRNAVERONA PHARMA PLC | 5,694,841 | $35.5B | 446.65% | |
| 63 | PRTAPROTHENA CORP PLC | 3,544,475 | $35.4B | 445.05% | |
| 64 | ACHCACADIA HEALTHCARE COMPANY IN | 1,114,466 | $32.9B | 412.94% | |
| 65 | SIBNSI BONE INC | 1,368,500 | $32.5B | 408.00% | |
| 66 | NVLSEURALPINE IMMUNE SCIENCES INC | 3,670,955 | $32.3B | 405.57% | |
| 67 | APLTAPPLIED THERAPEUTICS INC | 1,546,687 | $32.1B | 403.57% | |
| 68 | PCVXVAXCYTE INC | 640,760 | $31.6B | 397.69% | |
| 69 | —HARPOON THERAPEUTICS INC | 1,835,704 | $31.2B | 392.01% | |
| 70 | ALECALECTOR INC | 2,725,313 | $28.7B | 360.86% | |
| 71 | NBPI MAB | 606,070 | $28.5B | 358.25% | |
| 72 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 4,015,524 | $28.5B | 357.83% | |
| 73 | XENEXENON PHARMACEUTICALS INC | 2,497,917 | $27.7B | 347.55% | |
| 74 | PFEPFIZER INC | 750,000 | $27.5B | 345.96% | Call |
| 75 | SVASINOVAC BIOTECH LTD | 2,839,500 | $27.3B | 343.13% | |
| 76 | CRVSCORVUS PHARMACEUTICALS INC | 6,767,584 | $27.1B | 341.09% | |
| 77 | ARCTARCTURUS THERAPEUTICS HLDGS | 618,586 | $26.5B | 333.54% | |
| 78 | FLBFLUIDIGM CORP DEL | 3,553,703 | $26.4B | 331.87% | |
| 79 | —MERSANA THERAPEUTICS INC | 1,328,852 | $24.7B | 310.99% | |
| 80 | NXTCNEXTCURE INC | 2,711,013 | $23.9B | 299.85% | |
| 81 | AMGNAMGEN INC | 91,500 | $23.3B | 292.30% | |
| 82 | NVONOVO-NORDISK A S | 330,000 | $22.9B | 287.98% | |
| 83 | —9 METERS BIOPHARMA INC | 25,716,755 | $20.5B | 257.52% | |
| 84 | CTIC1USDCTI BIOPHARMA CORP | 9,520,600 | $20.5B | 257.27% | |
| 85 | ALCALCON AG | 351,380 | $19.9B | 250.69% | |
| 86 | OPHTEURIVERIC BIO INC | 3,411,806 | $19.2B | 241.86% | |
| 87 | OSH3EUROAK STR HEALTH INC | 334,400 | $17.9B | 224.61% | |
| 88 | TREURTRILLIUM THERAPEUTICS INC | 1,252,600 | $17.8B | 223.71% | |
| 89 | HRTXHERON THERAPEUTICS INC | 1,191,846 | $17.7B | 222.00% | |
| 90 | —FLEXION THERAPEUTICS INC | 1,684,000 | $17.5B | 220.33% | |
| 91 | TEVATEVA PHARMACEUTICAL INDS LTD | 1,935,200 | $17.4B | 219.15% | |
| 92 | GHGUARDANT HEALTH INC | 154,300 | $17.2B | 216.79% | |
| 93 | —PANDION THERAPEUTICS INC | 1,480,940 | $17.0B | 213.32% | |
| 94 | TOCAEURFORTE BIOSCIENCES INC | 340,480 | $16.5B | 207.60% | |
| 95 | SNDXSYNDAX PHARMACEUTICALS INC | 1,094,100 | $16.1B | 202.97% | |
| 96 | —ZYMEWORKS INC | 341,102 | $15.9B | 199.71% | |
| 97 | —SIERRA ONCOLOGY INC | 1,477,320 | $15.8B | 198.12% | |
| 98 | RLAYRELAY THERAPEUTICS INC | 350,000 | $14.9B | 187.36% | |
| 99 | PHGEBIOMX INC | 2,313,489 | $14.7B | 184.36% | |
| 100 | LRMRLARIMAR THERAPEUTICS INC | 886,560 | $13.4B | 169.04% |
Page 1 of 2Next